Visual Feedback Reach Training for Ataxia
Trial Summary
What is the purpose of this trial?
This trial compares two training methods to improve arm movements in people with cerebellar ataxia. It targets individuals who struggle with movement coordination due to cerebellum damage. The methods involve practicing reaching movements with feedback to enhance coordination.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Reach training with visual feedback for ataxia?
Is visual feedback reach training safe for humans?
How is the treatment 'Visual Feedback Reach Training for Ataxia' different from other treatments for ataxia?
This treatment is unique because it uses visual feedback to help patients improve their arm reaching movements, which can reduce unnecessary body movements and improve motor learning. Unlike other treatments that may rely on verbal feedback or robotic assistance, this approach focuses on visual cues, making it potentially less intimidating and more cost-effective.23689
Research Team
Amy J Bastian, PhD, PT
Principal Investigator
Kennedy Krieger Institute and Johns Hopkins School of Medicine
Eligibility Criteria
This trial is for individuals aged 22-80 with cerebellar ataxia due to stroke, tumor, or degeneration. It's not suitable for those with extrapyramidal symptoms, vestibular loss, sensory neuropathy, significant pain or dementia (Mini-Mental State exam score > 22), vision loss affecting task performance, or damage to brain areas outside the cerebellum.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo reinforcement or standard practice training for reaching movements over a 12-week period
Rest Period
Participants have a rest period between training phases
Follow-up
Participants are monitored for retention of training effects
Treatment Details
Interventions
- Reach training with visual feedback (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Lead Sponsor
Dr. Bradley L. Schlaggar
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Chief Executive Officer since 2018
MD/PhD from Washington University in St. Louis
Dr. Ali Fatemi
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Chief Medical Officer since 2019
MD from Medical University of Vienna, MBA from Johns Hopkins Carey Business School
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Dr. Diana W. Bianchi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Executive Officer since 2016
MD from Stanford University
Dr. Alison Cernich
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Chief Medical Officer since 2020
PhD in Clinical Psychology from University of Maryland
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University